This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

APP018

Novartis AG

Drug Names(s): D-4F

Description: D-4F is an oral apolipoprotein A-I (apoA-I) mimetic peptide. It contains 18 amino acids, versus 243 for apoA-I. apoA-I is the major protein of HDL particles, the good cholesterol that removes excess cholesterol and other lipids from artery walls and other tissues.

Deal Structure: In 2004, Novartis licensed APP018 from Bruin Pharmaceuticals.

Partners: Bruin Pharmaceuticals


APP018 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug